Copyright
©The Author(s) 2021.
World J Clin Cases. Aug 6, 2021; 9(22): 6234-6243
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6234
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6234
Autophagy modulators | Effects on CCA | Ref. |
Inhibitors | ||
Cisplatin combined with CQ/3-MA | ↓ Cell survival | Qu et al[30], 2017 |
CQ | ↓ Cell survival | Jia et al[31], 2018 |
↑ ER stress | ||
↑ Apoptosis | ||
ABC294640 with sorafenib and autophagy inhibitors | ↓ Cell survival | Ding et al[32], 2016 |
Salinomycin | ↓ Cell survival | Klose et al[35], 2018 |
Resveratrol | ↑ Oxidative stress | He et al[39], 2018 |
↑ Apoptosis | ||
Activators | ||
ABT737 combined with cisplatin | ↓ Chemoresistance | Fan et al[33], 2015 |
DHA | ↑ Apoptosis | Thongchot et al[34], 2018 |
NVP-BEZ235 | No effect on apoptosis | Yothaisong et al[45], 2013 |
↓ Cell survival | ||
Resveratrol | ↓ IL-6 | Thongchot et al[46], 2018 |
- Citation: Ninfole E, Pinto C, Benedetti A, Marzioni M, Maroni L. Role of autophagy in cholangiocarcinoma: Pathophysiology and implications for therapy. World J Clin Cases 2021; 9(22): 6234-6243
- URL: https://www.wjgnet.com/2307-8960/full/v9/i22/6234.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i22.6234